Effect of cerebral amyloid angiopathy on brain iron, copper, and zinc in alzheimer's disease

Journal of Alzheimer's Disease

Volumn 24, Issue 1, 2011, Pages 137-149

  Schrag, Matthew ^a   Crofton, Andrew ^a   Zabel, Matthew ^a   Jiffry, Arshad ^a   Kirsch, David ^a   Dickson, April ^a   Mao, Xiao Wen ^b   Vinters, Harry V ^c   Domaille, Dylan W ^d   Chang, Christopher J ^d   Kirsch, Wolff ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOMA LINDA UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Atomic absorption; coppersensor 1 (CS1); ferrous; non heme iron

Indexed keywords

AMYLOID BETA PROTEIN; COPPER; HEME; IRON; ZINC;

ALZHEIMER DISEASE; ARTICLE; BRAIN LEVEL; BRAIN TISSUE; CONTROLLED STUDY; GRAY MATTER; HISTOPATHOLOGY; HOMEOSTASIS; HUMAN; HUMAN TISSUE; NEUROPATHOLOGY; PRIORITY JOURNAL; TEMPORAL LOBE; VASCULAR AMYLOIDOSIS;

EID: 79955650486     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-101503     Document Type: Article

References (69)

1. Avramovich-Tirosh Y, Amit T, Bar-Am O, Weinreb O, Youdim M (2008) Physiological and pathological aspects of Abeta in iron homeostasis via 5'UTR in the APP mRNA and the therapeutic use of iron-chelators. BMC Neurosci 9(suppl) S2.
2. Bush A, Tanzi R (2008) Therapeutics for Alzheimer's disease based on the metal hypothesis. Neurotherapeutics 5, 421-432. (Pubitemid 351952485)
3. Huang X, Moir R, Tanzi R, Bush A, Rogers J (2004) Redox-active metals, oxidative stress and Alzheimer's disease pathol-ogy. Ann NY Acad Sci 1012, 153-163. (Pubitemid 38453522)
4. Molina-Holgado F, Gaeta H, Williams R, Francis P (2007) Metals ions and neurodegeneration. Biometals 20, 639-654. (Pubitemid 46776561)
5. Hallgren B, Sourander P (1960) The non-haemin iron in the cerebral cortex of Alzheimer's disease. J Neurochem 5, 307-310.
6. Plantin L, Lying-Tunell U, Kristensson K (1987) Trace ele-ments in the human central nervous system studied with neutron activation analysis. Biol Trace Elem Res 13, 69-75.
7. Ward N, Mason J (1987) Neutron activation analysis tech-niques for identifying elemental status in Alzheimer's disease. J Radioanal Nucl Chem 113, 515-526. (Pubitemid 18053924)
8. Corrigan FM, Reynolds GP, Ward NI (1991) Reductions of zinc and selenium in brain in Alzheimer's disease. Trace Elem Med 8, 1-5.
9. Griffiths P, Crossman A (1993) Distribution of iron in the basal ganglia and neocortex in postmortem tissue in Parkin-son's disease and Alzheimer's disease. Dementia 4, 61-65. (Pubitemid 23125352)
10. Stedman J, Spyrou N (1997) Elementalanalysis ofthefrontal lobe of "normal" brain tissue and that affected by Alzheimer's disease. J Radioanal Nucl Chem 217, 163-166.
11. Andrasi E, Farkas E, Gawlik D, Rosick U, Bratter P (2000) Brain iron and zinc contents of German patients with Alzheimer's disease. J Alzheimers Dis 2, 17-26. (Pubitemid 30353514)
12. Panayi A, Spyrou N, Part P (2001) Differences in trace ele-ment concentrations between Alzheimer and "normal" human brain tissue using instrumental neutron activation analysis. J Radioanal Nucl Chem 249, 437-441. (Pubitemid 32772321)
13. Religa D, Strozyk D, Cherny R, Volitakis I, Haroutunian V, Winblad B, Naslund J, Bush AI (2006) Elevated cortical zinc in Alzheimer's disease. Neurology 67, 69-75. (Pubitemid 44305464)
14. Magaki S, Raghavan R, Mueller C, Oberg K, Vinters HV, Kirsch WM (2007) Iron, copper and iron regulatory protein 2 in Alzheimer's disease and related dementia. Neurosci Lett 418, 72-76. (Pubitemid 46602696)
15. Kirsch W, McAuley G, Holshouser B, Petersen F, Ayaz M, Vinters HV, Dickson C, Haacke EM, Britt W, Larsen J, Kim I, Mueller C, Schrag M, Kido D (2009) Serial susceptibil-ity weighted MRI measures brain iron and microbleeds in dementia. J Alzheimers Dis 17, 599-609.
16. Schrag M, McAuley G, Pomakian J, Jiffry A, Tung S, Mueller C, Vinters HV, Haacke EM, Holshouser B, Kido D, Kirsch WM (2010) Correlation of hypointesities in susceptibility-weighted images to tissue histology in dementia patients with cerebral amyloid angiopathy: a post-mortem MRI study. Acta Neuropathol 119, 291-302.
17. Jellinger K (2010) Prevalence and impact of cerebrovascular lesions in Alzheimer's and Lewy Body diseases. Neurode-generDis7, 112-115.
18. Vinters HV (1987) Cerebral amyloid angiopathy: a critical review. Stroke 18, 311-326.
19. Vinters HV, Wang Z, Secor D (1996) Brain parenchymal and microvascular amyloid in Alzheimer's disease. Brain Pathol 6, 179-195. (Pubitemid 26160505)
20. Goodman L (1953) Alzheimer's disease; a clinico-pathologic analysis of 23 cases with a theory on pathogenesis. J Nerv Ment Dis 118, 97-130.
21. Cullen K, Kocsi Z, Stone J (2005) Pericappillary haem-rich deposits: evidence for microhemorrhages in aging human cerebral cortex. J Cereb Blood Flow Metab 25, 1656-1667. (Pubitemid 41683176)
22. Cullen K, Kocsi Z, Stone J (2006) Microvascular pathology in the aging human brain: evidence that senile plaques are sites of microhemorrhages. Neurobiol Aging 27, 1786-1796. (Pubitemid 44572582)
23. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82, 239-259.
24. Greenberg S, Vonsattel JP (1997) Diagnosis of cerebral amyloid angiopathy. Stroke 28, 1418-1422.
25. Vinters HV, Vonsattel JP (2000) Neuropathologic features and grading of Alzheimer-related and sporadic CAA. In Cerebral amyloid angiopathy in Alzheimer's Disease and Related Disorders, Verbeek MM, de Wall RMW, Vinters HV, eds. Kluwer Academic, Dordrecht, The Netherlands, pp. 137-155.
26. Schrag M, Dickson A, Jiffry A, Kirsch D, Vinters HV, Kirsch WM (2010) The effect of formalin fixation on the levels of brain transition metals in archived samples. Bio Metals 23, 1123-1127.
27. Smith MA, Harris P, Sayre L, Perry G (1997) Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc Natl Acad Sci USA 94, 9866-9868. (Pubitemid 27408156)
28. Okon EE (1998) Cytophotometric determination of non-heme iron in hepatocytes. II. Effect of fixation on the cell iron content. Tsitologiia 40, 520-523.
29. Miller E, Zeng L, Domaille D, Chang C (2006) Preparation and use of coppersensor-1, a synthetic fluorophore for Livecell copper imaging. Nat Protoc 1, 824-827.
30. Zeng L, Miller E, Pralle A, Isacoff E, Chang CJ (2006) A selective turn-on fluorescent sensor for imaging copper in living cells. J Am Chem Soc 128, 10-11. (Pubitemid 43100825)
31. Domaille D, Que E, Chang CJ (2008) Synthetic fluorescent sensors for studying the cell biology of metals. Nature Chem Biol4, 168-175. (Pubitemid 351265326)
32. Finney L, Chishti Y, Khare T, Giometti C, Levina A, Lay PA, Vogt S (2010) Imaging metals in proteins by combining electrophoresis with rapid X-ray fluorescence mapping. ACS Chem Biol 5, 577-587.
33. Burton E, Barber R, Mukaetova-Ladinska E, Robson J, Perry R, Jaros E, Kalaria R, O'Brien J (2009) Medial temporal lobe atrophy on MRI differentiates Alzheimer's disease from dementia with Lewy bodies and vascular cognitive impairment: a prospective study with pathological verification of diagnosis. Brain 132, 195-203.
34. Hallgren B, Sourander P (1958) The effect of age on the nonhaemin iron in the human brain. J Neurochem 3, 41-51.
35. Markesbery W (1984) Brain trace elements concentrations in aging. Neurobiol Aging 5, 19-28. (Pubitemid 14088820)
36. Smith DG, Cappai R, Barnham KJ (2007) The redox chemistry ofthe Alzheimer's disease amyloid beta peptide. Biochim Biophys Acta 1768, 1976-1990. (Pubitemid 47125850)
37. Markesbery W (1999) The role of oxidative stress in Alzheimer disease. Arch Neurol 56, 1449-1452.
38. Lovell M, Robertson J, Teesdale W, Campbell J, Markesbery W (1998) Copper, iron and zinc in Alzheimer's disease senile plaques. J Neurol Sci 158, 47-52. (Pubitemid 28277534)
39. Dhenain M, Privat N, Duyckaerts, C, Jacob R (2002). Senile plaques do not induce susceptibility effects in T2*-weighted MR microscopic images. NMR Biomed 15, 197-203. (Pubitemid 34520660)
40. Collingwood J, Chong R, Kasama T, Cervera-Gontard L, Dunin-Borkowski RE, Perry G, Posfai M, Siedlak SL, Simpson ET, Smith MA, Dobson J (2008) Three-dimensional tomographic imaging and characterization of iron compounds within Alzheimer's plaque core material. J Alzheimers Dis 14, 235-245. (Pubitemid 352040039)
41. Rottkamp C, Raina A, Zhu X, Gaier E, Bush AI, Atwood CS, Chevion M, Perry G, Smith MA (2001) Redox-active iron mediates amyloid-beta toxicity. Free Radic Biol Med 30, 447-450. (Pubitemid 32155543)
42. Smith MA, Wehr K, Harris P, Siedlak S, Connor JR, Perry G (1998) Abnormal localization of iron regulatory protein in Alzheimer's disease. Brain Res 788, 232-236. (Pubitemid 28202166)
43. Leipuviene R, Theil E (2007) The family of iron respon-sive RNA structures regulated by changes in cellular iron and oxygen. Cell Mol Life Sci 64, 2945-2955. (Pubitemid 351152243)
44. Rogers JT, Bush AI, Cho HH, Smith DH, Thomson AM, Friedlich AL, Lahiri DK, Leddman PJ, Huang X, Cahill CH (2008) Iron and the translation of the amyloid precursor pro-tein (APP) and ferritin mRNAs: riboregulation against neurol oxidative damage in Alzheimer's disease. Biochem Soc Trans 36(Pt6), 1282-1287.
45. Pinero DJ, Hu J, Connor JR (2000) Alterations in the inter-action between iron regulatory proteins and their responsive element in normal and Alzheimer's diseased brains. Cell Mol Biol 46, 761-776.
46. Connor JR, Snyder BS, Beard J, Fine R, Mufson E (1992) Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's disease. J Neurosci Res 31, 327-335.
47. Connor JR, Snyder BS, Arosio P, Loeffler DA, LeWitt P (1995) A quantitative analysis of isoferritins in select regions of aged, parkinsonian and Alzheimer's diseased brains. JNeu-rochem 65, 717-724.
48. Dedman DJ, Treffry A, Candy JM, Taylor GA, Morris CM, Bloxham CA, Perry RH, Edwardson JA, Harrison PM (1992) Iron and aluminum in relation to brain ferritin in normal indi-viduals and Alzheimer's disease and chronic renal dialysios patients. Biochem J 287, 509-514.
49. Loeffler D, Connor J, Juneau P, Snyder B, Kanaley L, DeMaggio A, Nguyen H, Brickman B, LeWitt P (1995) Trans-ferrin and iron in normal, Alzheimer's disease and Parkinson's disease brain regions. J Neurochem 65, 710-716.
50. Kalaria RN, Kroon SN (1992) Transferrin receptors of rat and human brain and cerebral microvessels and their status in Alzheimer's disease. Brain Res 585, 87-93.
51. Morris CM, Candy JM, Kerwin JM, Edwardson JA (1994) Transferrin receptors in the normal human hippocampus and in Alzheimer's disease. Neuropathol Appl Neurobiol 20, 473-477. (Pubitemid 24326470)
52. Jefferies WA, Food MR, Gabathuler R, Rothenberger S, Yamada O, McGeer PL (1996) Reactive microglia specifically associated with amyloid plaques in Alzheimer's disease brain tissue express melanotransferrin. Brain Res 712, 122-126. (Pubitemid 26099932)
53. Schipper HM, Cisse S, Stopa EG (1995) Expression of heme oxygenase-1 in the senescent and Alzheimer's diseased brain. Ann Neurol 37, 758-768.
54. Schipper HM, Song W, Zukor H, Hascalovici JR, Zeligman D (2009) Heme oxygenase-1 and neurodegeneration; expanding frontiers of engagement. J Neurochem 110, 469-485.
55. Zukor H, Song W, Liberman A, Mui J, Vali H, Fillebeen C, Pantopoulos K, Wu TD, Guerquin-Kern JL, Schipper HM (2009) HO-1 mediated macroautophagy: a mechanism for unregulated iron deposition in aging and degenerating neural tissues. J Neurochem 109, 776-791.
56. Lerner-Marmarosh N, Shen J, Torno M, Kravets A, Hu Z, Maines M (2005) Human biliverdin reductase: a member of the insulin receptor substrate family with ser-ine/threonine/tyrosine kinase activity. Proc Natl Acad Sci US A 102, 7109-7114. (Pubitemid 40696342)
57. Florczyk U, Jozkowicz A, Dulak J (2008) Biliverdin reduc-tase: new features of an old enzyme and its potential therapeutic significance. Pharm Reports 60, 38-48. (Pubitemid 351586541)
58. Mueller C, Zhou W, VanMeter A, Heiby M, Magaki S, Ross M, Espina V, Schrag M, Dickson C, Liotta L, Kirsch W (2010) The heme degradation pathway is a promising serum biomarker source for the early detection of Alzheimer's disease. J Alzheimers Dis 19, 1081-1091.
59. Crapper McLachlan DR, Dalton AJ, Kruck TP, Bell MY, Smith WL, Kalow W, Andrews DF (1991) Intramusclar des-ferrioxamine in patients with Alzheimer's disease. Lancet 337, 1304-1308.
60. Lannfelt L, Blennow K, Zetterberg H, Batsman S, Ames D, Harrison J, Masters CL, Targum S, Bush AI, Murdoch R, Wilson J, Ritchie CW, PBT2-201-EURO Study Group (2008) Safety, efficacy and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease; a phase IIa, double blind randomized placebo controlled trial. Lancet Neurol 7, 779-786.
61. Deibel M, Ehmann W, Markesbery W (1996) Copper, iron and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress. J Neurol Sci 143, 137-142. (Pubitemid 26402800)
62. Cornett C, Markesbery W, Ehmann W (1998) Imbalances of trace elements related to oxidative damage in Alzheimer's disease brain. Neurotoxicology 19, 339-345.
63. Panayi A, Spyrou N, Iverson B, White M, Part P (2002) Deter-mination of cadmium and zinc in Alzheimer's brain tissue using inductively coupled plasma mass spectrometry. JNeurol Sci 195, 1-10. (Pubitemid 34175093)
64. Corrigan FM, Reynolds GP, Ward NI (1993) Hippocampal tin, aluminum and zinc in Alzheimer's disease. Biometals 6, 149-154.
65. Friedlich A, Lee J, van Groen T, Cherny RA, Volitakis I, Cole TB, Palmiter RD, Koh JY, Bush AI (2004) Neuronal zinc exchange with the blood vessel wall promotes cerebral amy-loid angiopathy in an animal model of Alzheimer's disease. J Neurosci 24, 3453-3459. (Pubitemid 38451911)
66. Yang L, McRae R, Henary MM, Patel T, Lai B, Vogt S, Fahrni CJ (2005) Imaging of the intracellular topography of copper with a fluorescent sensor and by synchrotron X-ray fluorescence microscopy. Proc Natl Acad Sci USA 102, 11179-11184. (Pubitemid 41153794)
67. Tokuda E, Okawa E, Ono S (2009) Dysregulation of intra-cellular copper trafficking pathway in a mouse model of mutant copper/zinc superoxide dismutase-linked familial amyotrophic lateral sclerosis. J Neurochem 111, 181-91.
68. El Meskini R, Crabtree KL, Cline LB, Mains RE, Eipper BA, Ronnett GV (2007) ATP7A (Menkes protein) functions in axonal targeting and synaptogenesis. Mol Cell Neurosci 34, 409-421. (Pubitemid 46330045)
69. Prohaska J, Gybina A (2004) Intracellular copper transport in mammals. J Nutrition 134, 1003-1006. (Pubitemid 38619931)